(Q46521769)

22 December 2017

title

Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No. (English)

1 reference

22 December 2017

1 reference

Guido Finazzi

1

1 reference

22 December 2017

publication date

25 June 2008

1 reference

22 December 2017

Internal and emergency medicine

published in

1 reference

22 December 2017

volume

3

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

197-200

1 reference

22 December 2017

Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11739-008-0169-4

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

21 January 2018

1 reference

12 December 2020

Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals

1 reference

12 December 2020

Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study

1 reference

12 December 2020

Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry

1 reference

12 December 2020

Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus

1 reference

12 December 2020

Efficacy and safety of low-dose aspirin in polycythemia vera

1 reference

12 December 2020

Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients

1 reference

12 December 2020

The management of thrombosis in the antiphospholipid-antibody syndrome

1 reference

12 December 2020

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

1 reference

12 December 2020

A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis

1 reference

12 December 2020

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis

1 reference

12 December 2020

Assessment of the 2006 revised antiphospholipid syndrome classification criteria

1 reference

12 December 2020

Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals

1 reference

12 December 2020

10.1007/S11739-008-0169-4

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017